0.888
price up icon0.91%   0.008
after-market After Hours: .90 0.012 +1.35%
loading
Generation Bio Co stock is traded at $0.888, with a volume of 1.58M. It is up +0.91% in the last 24 hours and down -23.45% over the past month. Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
See More
Previous Close:
$0.88
Open:
$0.99
24h Volume:
1.58M
Relative Volume:
4.89
Market Cap:
$59.31M
Revenue:
-
Net Income/Loss:
$-126.61M
P/E Ratio:
-0.4531
EPS:
-1.96
Net Cash Flow:
$-60.14M
1W Performance:
-2.43%
1M Performance:
-23.45%
6M Performance:
-69.69%
1Y Performance:
-53.51%
1-Day Range:
Value
$0.8756
$1.00
1-Week Range:
Value
$0.8501
$1.0092
52-Week Range:
Value
$0.75
$4.65

Generation Bio Co Stock (GBIO) Company Profile

Name
Name
Generation Bio Co
Name
Phone
857-529-5908
Name
Address
301 BINNEY STREET, CAMBRIDGE
Name
Employee
174
Name
Twitter
@generationbio
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
GBIO's Discussions on Twitter

Compare GBIO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GBIO
Generation Bio Co
0.888 59.31M 0 -126.61M -60.14M -1.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.26 109.26B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
703.43 77.30B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
665.19 39.78B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.01 32.38B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.67 27.25B 3.30B -501.07M 1.03B -2.1146

Generation Bio Co Stock (GBIO) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-19-23 Downgrade TD Cowen Outperform → Market Perform
Nov-08-22 Initiated Canaccord Genuity Buy
Dec-14-21 Downgrade William Blair Outperform → Mkt Perform
Jun-08-21 Initiated JMP Securities Mkt Outperform
Feb-24-21 Initiated William Blair Outperform
Feb-18-21 Initiated Needham Buy
Jul-07-20 Initiated Cowen Outperform
Jul-07-20 Initiated JP Morgan Overweight
Jul-07-20 Initiated Jefferies Buy
Jul-07-20 Initiated Wedbush Outperform
View All

Generation Bio Co Stock (GBIO) Latest News

pulisher
03:13 AM

Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Jane Street Group LLC - Defense World

03:13 AM
pulisher
01:05 AM

Layoff Tracker: Apellis, Barinthus, Repare Among Latest to Trim Workforces - BioSpace

01:05 AM
pulisher
Jan 14, 2025

Generation Bio director Quinn Anthony buys $203k in shares By Investing.com - Investing.com South Africa

Jan 14, 2025
pulisher
Jan 14, 2025

Anthony G. Quinn Acquires 125,791 Shares of Generation Bio Co. (NASDAQ:GBIO) Stock - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Anthony G. Quinn Acquires 85,000 Shares of Generation Bio Co. (NASDAQ:GBIO) Stock - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Generation Bio director Quinn Anthony buys $203k in shares - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

Seattle immunotherapy startup Umoja Biopharma raises $100M - GeekWire

Jan 14, 2025
pulisher
Jan 13, 2025

Generation Bio chief scientific officer Matthew Stanton to leave role - MSN

Jan 13, 2025
pulisher
Jan 11, 2025

Generation Bio (GBIO) Stock Price, News & Analysis - MarketBeat

Jan 11, 2025
pulisher
Jan 10, 2025

Needham & Company LLC Issues Pessimistic Forecast for Generation Bio (NASDAQ:GBIO) Stock Price - Defense World

Jan 10, 2025
pulisher
Jan 09, 2025

Generation Bio's SWOT analysis: ctLNP tech drives pivot to autoimmune stock - Investing.com Canada

Jan 09, 2025
pulisher
Jan 09, 2025

Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies - Business Wire

Jan 09, 2025
pulisher
Jan 08, 2025

Finance Watch: Generation Bio, CytomX Right-Size Operations Ahead Of J.P. Morgan - Citeline News & Insights

Jan 08, 2025
pulisher
Jan 08, 2025

Needham & Company LLC Lowers Generation Bio (NASDAQ:GBIO) Price Target to $8.00 - MarketBeat

Jan 08, 2025
pulisher
Jan 07, 2025

Barclays PLC Boosts Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jan 07, 2025
pulisher
Jan 07, 2025

Generation Bio Announces Executive Departures and Appointments - Defense World

Jan 07, 2025
pulisher
Jan 07, 2025

Generation Bio Restructures Leadership and Focuses on siRNA - TipRanks

Jan 07, 2025
pulisher
Jan 06, 2025

Generation Bio Co. Announces Executive Changes - Marketscreener.com

Jan 06, 2025
pulisher
Jan 06, 2025

Generation Bio Co. to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases - Marketscreener.com

Jan 06, 2025
pulisher
Jan 06, 2025

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune - EIN News

Jan 06, 2025
pulisher
Jan 06, 2025

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases - The Manila Times

Jan 06, 2025
pulisher
Jan 06, 2025

Generation Bio Pivots to Autoimmune Disease Treatment with Novel T Cell Technology - StockTitan

Jan 06, 2025
pulisher
Jan 01, 2025

Generation Bio Co. (NASDAQ:GBIO) Holdings Raised by State Street Corp - Defense World

Jan 01, 2025
pulisher
Dec 30, 2024

Generation Bio Co. (NASDAQ:GBIO) Short Interest Up 16.3% in December - MarketBeat

Dec 30, 2024
pulisher
Dec 25, 2024

Contrasting Spyre Therapeutics (NASDAQ:SYRE) & Generation Bio (NASDAQ:GBIO) - Defense World

Dec 25, 2024
pulisher
Dec 20, 2024

Next-Generation Biomanufacturing Market Vendor and Technology Assessment Report 2024-2031 - openPR

Dec 20, 2024
pulisher
Dec 18, 2024

Generation Bio stock hits 52-week low at $1.11 By Investing.com - Investing.com South Africa

Dec 18, 2024
pulisher
Dec 17, 2024

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio - BioSpace

Dec 17, 2024
pulisher
Dec 17, 2024

Generation Bio stock hits 52-week low at $1.11 - Investing.com

Dec 17, 2024
pulisher
Dec 15, 2024

Generation Bio's SWOT analysis: innovative dna tech stock faces clinical hurdles By Investing.com - Investing.com South Africa

Dec 15, 2024
pulisher
Dec 15, 2024

Generation Bio's SWOT analysis: innovative dna tech stock faces clinical hurdles - Investing.com Australia

Dec 15, 2024
pulisher
Dec 09, 2024

BB Biotech AG Reduces Stake in Generation Bio Co: An In-Depth Analysis - GuruFocus.com

Dec 09, 2024
pulisher
Dec 09, 2024

“Next-Generation Bioformulations” for Plant Growth Promotion and Stress Mitigation: A Promising Approach for Sustainable Agriculture | Request PDF - ResearchGate

Dec 09, 2024
pulisher
Dec 04, 2024

Molecular Diagnostics Market to grow by USD 7.92 Billion (2024-2028), driven by rising age-related diseases; Report highlights AI-driven transformationTechnavio - Lelezard

Dec 04, 2024
pulisher
Dec 02, 2024

US Penny Stocks Spotlight: LiveOne And 2 Other Promising Picks - Simply Wall St

Dec 02, 2024
pulisher
Dec 02, 2024

Baker BROS. Advisors LP Acquires 737,988 Shares of Generation Bio Co. (NASDAQ:GBIO) - MarketBeat

Dec 02, 2024
pulisher
Nov 23, 2024

Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024
pulisher
Nov 21, 2024

Generation Bio Co. Reports Q3 2024 Financials and Progress - TipRanks

Nov 21, 2024
pulisher
Nov 20, 2024

Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

SK Bioscience's SKYCellflu Recognized as Next-generation World-class Product - BusinessKorea

Nov 19, 2024
pulisher
Nov 14, 2024

Generation Bio's SWOT analysis: innovative gene therapy stock faces timeline hurdles - Investing.com Australia

Nov 14, 2024
pulisher
Nov 12, 2024

Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections - Business Wire

Nov 12, 2024
pulisher
Nov 11, 2024

Next Generation Gene pioneers gene therapy approach with China data - BioWorld Online

Nov 11, 2024
pulisher
Nov 11, 2024

FY2024 EPS Estimates for Generation Bio Boosted by Analyst - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Earnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance

Nov 10, 2024
pulisher
Nov 08, 2024

Landlord’s alleged breach doesn’t justify end of rent payments - Massachusetts Lawyers Weekly

Nov 08, 2024
pulisher
Nov 08, 2024

Generation Bio Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance UK

Nov 08, 2024

Generation Bio Co Stock (GBIO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.20
price up icon 9.31%
$30.74
price up icon 2.36%
$72.46
price up icon 0.74%
$361.64
price down icon 0.84%
biotechnology ONC
$201.72
price up icon 0.36%
$113.67
price up icon 1.10%
Cap:     |  Volume (24h):